PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING

Pfizer has developed its own generative AI platform called “Charlie,” named after Pfizer co-founder Charles Pfizer.

Point sur le baromètre 2024 sur la santé connectée par Ipsos pour EDHEC et Bristol Myers Squibb concernant l'accès inégal à ces technologies

Le laboratoire Bristol Myers Squibb et EDHEC Business School proposent une nouvelle vague du baromètre sur la santé connectée.

PathAI will develop AI digital pathology algorithms that will be deployed using Roche's Digital Pathology solution.

The partnership will focus on designing molecular glues for unspecified therapeutic targets.

TenAces will develop an AI platform to help identify protein interactions that naturally occur in the body to assist with targeted protein degradation.

Background Until now, scholarship on innovation processes in healthcare systems lack an in-depth appreciation of tensions. Tensions often revolve around barriers and result from individual assessments and prioritizations that guide actions to eventually overcome these barriers. In order to develop a more differentiated understanding of tensions’ role in healthcare innovation processes, this paper aims to shed light on the multifaceted ways in which tensions emerge, are being dealt with, and how they hinder or, at times, facilitate innovation processes. Methods A systematic review of published and grey literature was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline. The review involved searching three databases for original research articles and manually searching citations. Twenty-nine original full texts were identified, evaluated, and coded. These include papers on innovation in healthcare systems that investigated innovation-related organizational tensions. The findings were synthesized into different types of tensions in healthcare system innovation and the descriptions of the conflicting elements. We also analyzed the investigated innovations by type, process stages, and across different countries and healthcare systems. Results A total of forty-two tensions were identified and grouped into nine categories. Organizing tensions were predominant, followed by learning/belonging, performing, and performing/organizing tensions. Tensions most frequently occurred in the implementation phase and in the form of a dilemma. Included studies were conducted mainly in government-funded healthcare systems. Conclusion Our data suggest that innovation processes in healthcare systems are impaired by conflicts between contradictory elements, working cultures, and convictions and the organizational and regulatory context. Since the majority of the tensions we collected in our study can be addressed, future policy-making and research should take advantage of this fact and develop strategies that significantly influence the successful management of tensions and thus improve the implementation of innovations.

The Pharma AI Readiness Index assesses how prepared top pharmaceutical companies are to adopt and respond to rapidly evolving AI technologies.

Lire l'article complet sur : www.cbinsights.com

Its AI model can predict the accumulation of amyloid-beta protein, a major Alzheimer's biomarker.

Le décret définissant les conditions de mise en œuvre et d'entrée en vigueur de la prescription électronique est paru au « Journal officiel » ce jeudi 21 décembre.  De quoi on parle ? Le texte en question définit la e-prescription comme étant la dématérialisation des prescriptions de soins, de produits de santé et de prestations établies ou exécutées par les professionnels de santé et leur transmission à l'assurance maladie par voie électronique.